Palaniyandi, Suresh Selvaraj; Ferreira, Julio Cesar Batista 
; Brum, Patricia Chakur; Mochly-Rosen, Daria
Source: Journal of Cellular and Molecular Medicine. Unidade: EEFE
Subjects: INSUFICIÊNCIA CARDÍACA, INFARTO DO MIOCÁRDIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALANIYANDI, Suresh Selvaraj et al. PKC 'beta' 2 inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses. Journal of Cellular and Molecular Medicine, v. 15, n. 8, p. 1769\20131777, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1582-4934.2010.01174.x. Acesso em: 29 set. 2024.APA
Palaniyandi, S. S., Ferreira, J. C. B., Brum, P. C., & Mochly-Rosen, D. (2011). PKC 'beta' 2 inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses. Journal of Cellular and Molecular Medicine, 15( 8), 1769\20131777. doi:10.1111/j.1582-4934.2010.01174.xNLM
Palaniyandi SS, Ferreira JCB, Brum PC, Mochly-Rosen D. PKC 'beta' 2 inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses [Internet]. Journal of Cellular and Molecular Medicine. 2011 ; 15( 8): 1769\20131777.[citado 2024 set. 29 ] Available from: https://doi.org/10.1111/j.1582-4934.2010.01174.xVancouver
Palaniyandi SS, Ferreira JCB, Brum PC, Mochly-Rosen D. PKC 'beta' 2 inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responses [Internet]. Journal of Cellular and Molecular Medicine. 2011 ; 15( 8): 1769\20131777.[citado 2024 set. 29 ] Available from: https://doi.org/10.1111/j.1582-4934.2010.01174.x
